Volume 1 Issue 3
Sep.  2017
Turn off MathJax
Article Contents
Zequn Zheng, Qi Tang, Zhenqing Feng. CAR-T cell therapy and its application in clinical cancer treatment[J]. Blood&Genomics, 2017, 1(3): 1-6. doi: 10.46701/APJBG.2017032017040
Citation: Zequn Zheng, Qi Tang, Zhenqing Feng. CAR-T cell therapy and its application in clinical cancer treatment[J]. Blood&Genomics, 2017, 1(3): 1-6. doi: 10.46701/APJBG.2017032017040

CAR-T cell therapy and its application in clinical cancer treatment

doi: 10.46701/APJBG.2017032017040
  • Publish Date: 2017-09-30
  • Immunotherapy is regarded as the most significant method for cancer treatment in recent years. Chimeric antigen receptor T cells (CAR-T) technology, one form of target immunotherapy, has made a great breakthrough in hematological malignancies treatment and also a few progress in solid tumor treatment. This article reviews the history and mechanism of CAR-T, as well as the advantages and limitations of CAR-T in clinical cancer treatment. Then the review mainly discussed the clinical trial progress of CAR-T cell therapy in solid tumor treatment. A primary obstacle of CAR-T therapy is the heterogeneity in solid tumors. With an increasing number of solid tumor surface antigens being discovered, different varieties of CARs have been designed to treat solid tumors and have made some progress in clinical trial. In the end, this review puts forward a possible development direction of CAR-T.

     

  • loading
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1417) PDF downloads(1188) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return